Stock Movers

- SoftBank Group Corp. agreed to acquire DigitalBridge Group Inc. (DBRG) in a deal valuing the data center investor at $4 billion including debt. That caused shares of DigitalBridge to soar. The Japanese conglomerate will pay $16 per share in cash for New York-listed DigitalBridge as part of its push to invest in digital infrastructure. The transaction is expected to close in the second half of 20...

On this episode of Stock Movers: - Nvidia (NVDA) shares were down 1.6% at $187.45 in early trading due to broader jitters about the technology sector and its agreement to license technology from Groq. The deal valued Groq at around $20 billion and will involve Nvidia hiring many of Groq's key employees, according to reports. - SoftBank Group Corp. agreed to acquire DigitalBridge Group Inc. (DBRG)...

On this episode of Stock Movers: - Novo Nordisk (NVO) cut the price of its obesity drug Wegovy in China as the Danish drugmaker gears up for a potential flood of copycats. The reduction will “help alleviate the treatment burden for patients and improve their quality of life,” a spokesperson said by email. The list prices for the two highest dosages of Wegovy were cut by half in some Ch...

On this episode of Stock Movers: - Shares of private equity firm DigitalBridge Group (DBRG) soared in premarket trading as Japan's SoftBank Group is said to near a deal to acquire DigitalBridge. The Japanese conglomerate could announce an agreement as soon as Monday for New York-listed DigitalBridge, according to sources who asked not to be identified because the information is private. Terms of t...

On this episode of Stock Movers: - Shares of private equity firm DigitalBridge Group (DBRG) soared in premarket trading as Japan's SoftBank Group is said to near a deal to acquire DigitalBridge. The Japanese conglomerate could announce an agreement as soon as Monday for New York-listed DigitalBridge, according to sources who asked not to be identified because the information is private. Terms of t...

On this episode of Stock Movers: - Shares in miner Fresnillo Mining jump as much as 4.2% due to the continued metal rally - BioGaia gains as much as 4.1% as DNB Carnegie lifts its price target on the Swedish probiotics firm and says the stock may break out on the upside from its five-year trading range in 2026 as margins improve. - Rheinmetall and other defense stocks are down after Trump said a l...

On this episode of Stock Movers: - Shares in miner Fresnillo Mining jump as much as 4.2% due to the continued metal rally - International Personal Finance (IPF) rises as much as 6.8% in London trading after Basepoint agreed to buy the consumer finance company in a deal valuing IPF at about £543 million. - Rheinmetall and other defense stocks are down after Trump said a lot of progress was ma...

On this episode of Stock Movers, we look at some the week's biggest gainers and decliners: - Warner Bros. Discovery (WBD) saw a modest weekly gain as Paramount continues to try to counter Netflix's bid to buy it. Larry Ellison is throwing his personal fortune behind Paramount Skydance’s bid for Warner Bros. Discovery Inc., aiming to give his son’s company an advantage in a fiercely con...

On this episode of Stock Movers: - Warner Bros. Discovery (WBD) shares slid after a report from the New York Post that Paramount Skydance could walk away from its $30-per-share cash bid and instead litigate against the company’s board for how it handled the process. - Sable Offshore (SOC) shares fell as much as 17% after the Environmental Defense Center and Center for Biological Diversity fi...

On this episode of Stock Movers: - Nvidia (NVDA) agreed to a licensing deal with artificial intelligence startup Groq, furthering its investments in companies connected to the AI boom and gaining the right to add a new type of technology to its products. The world’s largest publicly traded company has paid for the right to use Groq’s technology and will integrate its chip design into f...

On this episode of Stock Movers: - Shares of Nvidia (NVDA) edge higher in the premarket session as the company agreed to a licensing deal with artificial intelligence startup Groq, furthering its investments in companies connected to the AI boom and gaining the right to add a new type of technology to its products. - Shares of Indian technology services provider Coforge Ltd. (COFORGE IN) declined...

On this episode of Stock Movers: - Shares of Nvidia (NVDA) edge higher in the premarket session as the company takes agreed to a licensing deal with artificial intelligence startup Groq, furthering its investments in companies connected to the AI boom and gaining the right to add a new type of technology to its products. - Shares of Sidus Space (SIDU) rallied as much as 30 percent ahead of the US...

- Nike (NKE) shares got a boost on Wednesday after a filing showed that Apple CEO Tim Cook purchased $2.95 million worth of shares on Dec. 22. Cook is Nike’s lead independent director and served as a director since 2005, according to the company’s website. The filing shows Cook purchased 50,000 Class B common stock at a weighted average price of $58.97. - Costco (COST) rose after recei...

- Intel (INTC) shares fell Wednesday after a report said that Nvidia Corp. halted a test to use Intel’s production process to make advanced chips. Nvidia recently tested the so-called 18A process but stopped moving forward, Reuters reported, citing two unidentified people familiar with the matter. Spokespeople for Nvidia and Intel didn’t immediately respond to requests for comment. An...

On this episode of Stock Movers: - Shares of Intel (INTC) fell in the early session after Reuters reported that Nvidia halted a test that uses the chip manufacturer’s 18A technology to produce its chips. Nvidia recently tested whether it could manufacture its chips using Intel’s 18A production process but stopped moving forward, Reuters reported, citing two people familiar with the mat...

On this episode of Stock Movers: - Shares of Dynavax Technologies (DVAX) soared in premarket trading after Sanofi agreed to buy Dynavax for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise. The French drugmaker will pay $15.50 a share in cash for Dynavax, 39% above the Emeryville, California-based firm’s closing price Tuesda...

On This episode of Stock Movers: - BP agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion. - French biotech company Abivax started the year with a market value of less than $500 million. After a meteoric rally, it’s now worth more than $8 billion — and some analysts see the potential for even more gains -...

On This episode of Stock Movers: - BP Plc agreed to sell a majority stake in its Castrol lubricants division to US investment firm Stonepeak Partners to raise about $6 billion. - Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion, as the French drugmaker tries to expand a vaccines business currently anchored by its flu shot franchise. - Fresnillo and other european mining stock...

On this episode of Stock Movers: - Novo Nordisk (NVO) shares rallied in trading today following the drugmaker getting US approval to sell a pill version of its blockbuster obesity shot Wegovy. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved to help people lose weight or maintain previous weight loss over the long term. The pill is...

On this episode of Stock Movers: - Novo Nordisk (NVO) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ab...

On this episode of Stock Movers: - Novo Nordisk (NOVOB) won approval to sell a pill version of its obesity shot Wegovy in the US, to help people lose weight or maintain previous weight loss over the long term. The company will start selling the pill in the US in early January, and it is approved based on the results of the Oasis 4 trial, which found people taking the pill lost about 13.6% of their...

On this episode of Stock Movers: - Novo Nordisk (NOVOB) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly (LLY). The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker&rs...

On this episode of Stock Movers: - Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved t...

On this episode of Stock Movers: - Shares of Novo Nordisk (NVO) soared in premarket trading after the company won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly & Co. Novo will start selling the pill in the US in early January, the company said in a statement Monday. It is approved t...

On This episode of Stock Movers: - Novo Nordisk won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly. - Ryanair was fined more than €255 million ($300 million) by Italy’s antitrust watchdog for allegedly using an “abusive strategy” to thwart third-party travel agenci...